Amalgamated Bank’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,966
| Closed | -$2.94M | – | 2979 |
|
|
2022
Q3 | $2.94M | Buy |
11,966
+126
| +1% | +$34K | 0.03% | 657 |
|
|
2022
Q2 | $2.93M | Sell |
11,840
-76
| -0.6% | -$20.5K | 0.03% | 701 |
|
|
2022
Q1 | $3.95M | Buy |
11,916
+522
| +5% | +$161K | 0.03% | 606 |
|
|
2021
Q4 | $4.09M | Buy |
11,394
+1,335
| +13% | +$451K | 0.03% | 622 |
|
|
2021
Q3 | $3.27M | Sell |
10,059
-418
| -4% | -$142K | 0.03% | 716 |
|
|
2021
Q2 | $3.27M | Buy |
10,477
+7,744
| +283% | +$2.38M | 0.03% | 748 |
|
|
2021
Q1 | $871K | Sell |
2,733
-136
| -5% | -$43.5K | 0.03% | 655 |
|
|
2020
Q4 | $930K | Sell |
2,869
-5
| -0.2% | -$1.38K | 0.04% | 585 |
|
|
2020
Q3 | $796K | Sell |
2,874
-83
| -3% | -$23.9K | 0.03% | 574 |
|
|
2020
Q2 | $714K | Sell |
2,957
-4,591
| -61% | -$922K | 0.03% | 607 |
|
|
2020
Q1 | $1.1M | Sell |
7,548
-253
| -3% | -$42K | 0.03% | 584 |
|
|
2019
Q4 | $1.33M | Buy |
7,801
+491
| +7% | +$91K | 0.02% | 686 |
|
|
2019
Q3 | $1.3M | Buy |
7,310
+1,428
| +24% | +$309K | 0.03% | 641 |
|
|
2019
Q2 | $1.53M | Sell |
5,882
-567
| -9% | -$150K | 0.04% | 562 |
|
|
2019
Q1 | $1.84M | Buy |
6,449
+134
| +2% | +$44.5K | 0.04% | 427 |
|
|
2018
Q4 | $2.05M | Sell |
6,315
-133
| -2% | -$46.2K | 0.06% | 307 |
|
|
2018
Q3 | $2.9M | Sell |
6,448
-129
| -2% | -$50.9K | 0.07% | 252 |
|
|
2018
Q2 | $2.69M | Sell |
6,577
-2,612
| -28% | -$946K | 0.07% | 260 |
|
|
2018
Q1 | $2.67M | Buy |
9,189
+558
| +6% | +$141K | 0.07% | 265 |
|
|
2017
Q4 | $1.62M | Buy |
8,631
+443
| +5% | +$82.7K | 0.04% | 467 |
|
|
2017
Q3 | $1.38M | Sell |
8,188
-29
| -0.4% | -$4.38K | 0.04% | 469 |
|
|
2017
Q2 | $1.18M | Buy |
8,217
+1,823
| +29% | +$245K | 0.04% | 550 |
|
|
2017
Q1 | $801K | Sell |
6,394
-1,286
| -17% | -$149K | 0.04% | 563 |
|
|
2016
Q4 | $865K | Buy |
7,680
+749
| +11% | +$86.8K | 0.04% | 552 |
|
|
2016
Q3 | $891K | Buy |
6,931
+6
| +0.1% | +$719 | 0.05% | 432 |
|
|
2016
Q2 | $859K | Buy |
6,925
+2,352
| +51% | +$234K | 0.05% | 444 |
|
|
2016
Q1 | $434K | Buy |
4,573
+566
| +14% | +$47.8K | 0.04% | 615 |
|
|
2015
Q4 | $362K | Sell |
4,007
-365
| -8% | -$31K | 0.04% | 635 |
|
|
2015
Q3 | $406K | Buy |
4,372
+54
| +1% | +$4.76K | 0.04% | 651 |
|
|
2015
Q2 | $284K | Buy |
4,318
+262
| +6% | +$17.4K | 0.03% | 1012 |
|
|
2015
Q1 | $290K | Buy |
+4,056
| New | +$220K | 0.04% | 694 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Amalgamated Bank's ABMD Position: Q4 2022 in Review
Amalgamated Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 11,966 shares — an estimated $2.94M sold.
Amalgamated Bank first reported a position in ABMD in Q1 2015 and held it in 31 quarters. The position peaked at $4.09M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Amalgamated Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Amalgamated Bank sold 11,966 Abiomed Inc shares in Q4 2022, an estimated $2.94M.
- Amalgamated Bank first reported a position in Abiomed Inc in Q1 2015 and held it in 31 quarters.
- Amalgamated Bank's Abiomed Inc position peaked at $4.09M in Q4 2021.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Amalgamated Bank's 13F filing for Q4 2022, filed 10 Feb 2023.